Paper41459531
Targeting the TLR4 axis with microbiota-oriented interventions and innovations in diabetes therapy: a narrative review.
Nikolaidis CG and 6 others. Front Immunol, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Targeting the TLR4 axis with microbiota-oriented interventions and innovations in diabetes therapy: a narrative review. Papers, record 41459531. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41459531
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting the TLR4 axis with microbiota-oriented interventions and innovations in diabetes therapy: a narrative review.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Toll-Like Receptor 4 | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetes Mellitus, Type 1 | Major topic |
| Humans | |
| Fecal Microbiota Transplantation | |
| Animals | |
| Signal Transduction | |
| NF-kappa B | |
| Insulin Resistance |
Source PubMed
References107
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26269668 | Role of the normal gut microbiota. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/26269668 | PubMed |
| 2 | 39486371 | Comparative study on physicochemical characterization and immunomodulatory activities of neutral and acidic Lycium barbarum polysaccharides. | Biomed Pharmacother | 2024 | https://conductscience.org/library/papers/39486371 | PubMed |
| 3 | 31901868 | Role of gut microbiota in type 2 diabetes pathophysiology. | EBioMedicine | 2020 | https://conductscience.org/library/papers/31901868 | PubMed |
| 4 | 33072084 | Probiotics in Medicine: A Long Debate. | Front Immunol | 2020 | https://conductscience.org/library/papers/33072084 | PubMed |
| 5 | 35227470 | Licorice extract ameliorates hyperglycemia through reshaping gut microbiota structure and inhibiting TLR4/NF-κB signaling pathway in type 2 diabetic mice. | Food Res Int | 2022 | https://conductscience.org/library/papers/35227470 | PubMed |
| 6 | 35402293 | Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35402293 | PubMed |
| 7 | 39061972 | Gut-Liver-Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies. | Biomedicines | 2024 | https://conductscience.org/library/papers/39061972 | PubMed |
| 8 | 33787393 | Role of TLR4/MyD88/NF-κB signaling in heart and liver-related complications in a rat model of type 2 diabetes mellitus. | J Int Med Res | 2021 | https://conductscience.org/library/papers/33787393 | PubMed |
| 9 | 23934958 | Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23934958 | PubMed |
| 11 | 28214524 | Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. | Gastroenterology | 2017 | https://conductscience.org/library/papers/28214524 | PubMed |
| 12 | 34025574 | Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34025574 | PubMed |
| 13 | 32005089 | Considering gut microbiota in treatment of type 2 diabetes mellitus. | Gut Microbes | 2020 | https://conductscience.org/library/papers/32005089 | PubMed |
| 14 | 36760813 | Review of the correlation between Chinese medicine and intestinal microbiota on the efficacy of diabetes mellitus. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36760813 | PubMed |
| 15 | 22190648 | Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. | Diabetes | 2012 | https://conductscience.org/library/papers/22190648 | PubMed |
| 16 | 36704100 | Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/36704100 | PubMed |
| 17 | 28358037 | Type 1 diabetes mellitus. | Nat Rev Dis Primers | 2017 | https://conductscience.org/library/papers/28358037 | PubMed |
| 18 | 26216961 | Microbiota regulates type 1 diabetes through Toll-like receptors. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26216961 | PubMed |
| 19 | 38735418 | Cordyceps: Alleviating ischemic cardiovascular and cerebrovascular injury - A comprehensive review. | J Ethnopharmacol | 2024 | https://conductscience.org/library/papers/38735418 | PubMed |
| 20 | 36066991 | Effect of acute TLR4 inhibition on insulin resistance in humans. | J Clin Invest | 2022 | https://conductscience.org/library/papers/36066991 | PubMed |
| 21 | 26668389 | Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/26668389 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42862482 | Toxic Metals and Metalloids Exposure and the Gut-Cardiometabolic Axis: A Narrative Review of Microbiome Dysbiosis, Gut Barrier Dysfunction, and Metabolic Inflammation. | Cardiovasc Toxicol | 2026 | https://conductscience.org/library/papers/42862482 | PubMed |
| 42731096 | Endocrine-Metabolic Crosstalk Between Diabetes Mellitus and Hypothyroidism: From Network Mechanisms to Translational Stratification. | FASEB J | 2026 | https://conductscience.org/library/papers/42731096 | PubMed |
| 42511619 | Mogroside V Alleviates Renal Injury in Diabetic Mice via Regulation of the TLR4/NF-κB Pathway and Modulation of ECM Remodeling. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511619 | PubMed |
| 42354909 | Gut Microbiota and Diabetic Complications: Potential Mechanisms, Microbial Signatures, and Clinical Implications. | Microorganisms | 2026 | https://conductscience.org/library/papers/42354909 | PubMed |
| 42353310 | Decoding the Gut-Fat-Heart Axis: From Molecular Communication Networks to Clinical Translation Strategies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353310 | PubMed |
| 42183994 | Lacticaseibacillus rhamnosus GR-1 Alleviates Escherichia coli-induced Autophagy-dependent Ferroptosis in Bovine Endometrial Epithelial Cells via FOXO1 Signaling. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/42183994 | PubMed |
| 41515205 | Modulating the Gut Microbiome in Type 2 Diabetes: Nutritional and Therapeutic Strategies. | Nutrients | 2025 | https://conductscience.org/library/papers/41515205 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MYD88 | 4615 | PubTator's text mining | https://conductscience.org/library/genes/4615 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41459531
GET https://conductscience.org/api/papers/v1/41459531/references?page=2